M Paesmans

1.7k total citations
41 papers, 1.2k citations indexed

About

M Paesmans is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M Paesmans has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in M Paesmans's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). M Paesmans is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). M Paesmans collaborates with scholars based in Belgium, France and Italy. M Paesmans's co-authors include Claudio Viscoli, M. P. Glauser, Ian Hann, H. Gaya, Sculier Jp, J‐M Verdebout, P. Delmotte, Céline Mascaux, J.J. Lafitte and Thierry Berghmans and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

M Paesmans

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Paesmans Belgium 16 876 418 277 246 211 41 1.2k
Maureen Reiner United States 22 707 0.8× 254 0.6× 129 0.5× 153 0.6× 51 0.2× 51 1.4k
Indrajit Fernando United Kingdom 15 702 0.8× 264 0.6× 109 0.4× 198 0.8× 99 0.5× 48 1.3k
J L Pico France 16 515 0.6× 170 0.4× 154 0.6× 186 0.8× 81 0.4× 31 1.4k
G. L. Phillips Canada 20 507 0.6× 171 0.4× 265 1.0× 168 0.7× 34 0.2× 47 1.6k
Luigi De Sio Italy 21 357 0.4× 472 1.1× 238 0.9× 144 0.6× 61 0.3× 39 1.2k
Josée Brossard Canada 18 304 0.3× 116 0.3× 375 1.4× 214 0.9× 40 0.2× 38 1.2k
Esteban Abella United States 17 512 0.6× 114 0.3× 178 0.6× 84 0.3× 37 0.2× 56 1.3k
Aleksandra Stanimirovic Canada 12 148 0.2× 903 2.2× 233 0.8× 269 1.1× 51 0.2× 13 1.3k
Martha L. Clabby United States 20 189 0.2× 392 0.9× 310 1.1× 625 2.5× 29 0.1× 36 1.7k
Isabel Badell Spain 24 311 0.4× 155 0.4× 234 0.8× 255 1.0× 19 0.1× 108 1.6k

Countries citing papers authored by M Paesmans

Since Specialization
Citations

This map shows the geographic impact of M Paesmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Paesmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Paesmans more than expected).

Fields of papers citing papers by M Paesmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Paesmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Paesmans. The network helps show where M Paesmans may publish in the future.

Co-authorship network of co-authors of M Paesmans

This figure shows the co-authorship network connecting the top 25 collaborators of M Paesmans. A scholar is included among the top collaborators of M Paesmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Paesmans. M Paesmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ameye, Lieveke, et al.. (2019). Cancer bronchique : le pronostic en soins intensifs dépendrait surtout de la complication. Revue des Maladies Respiratoires. 36(3). 333–341. 1 indexed citations
2.
Ameye, Lieveke, M Paesmans, Alexandre de Wind, et al.. (2018). Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation. PubMed. 39(5). 420–427. 2 indexed citations
3.
Paesmans, M, et al.. (2018). Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial.. PubMed. 67(4). 183–190. 43 indexed citations
4.
Paesmans, M, Lieveke Ameye, Michel Moreau, & Serge Rozenberg. (2010). Breast cancer screening in the older woman: An effective way to reduce mortality?. Maturitas. 66(3). 263–267. 12 indexed citations
5.
Klášterský, Jean, Ahmad Awada, M Paesmans, & Mickaël Aoun. (2010). Febrile neutropenia: A critical review of the initial management. Critical Reviews in Oncology/Hematology. 78(3). 185–194. 37 indexed citations
6.
Paesmans, M, et al.. (2007). Acute confusion in patients with systemic cancer. Journal of Neuro-Oncology. 83(3). 285–289. 15 indexed citations
7.
Berghmans, T., J.J. Lafitte, J. Lecomte, et al.. (2007). Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party. British Journal of Cancer. 96(11). 1644–1649. 10 indexed citations
8.
Sculier, Jean‐Paul, J.J. Lafitte, J. Lecomte, et al.. (2007). A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer. Annals of Oncology. 18(6). 1037–1042. 18 indexed citations
9.
Viscoli, Claudio, Alain Cometta, Winfried V. Kern, et al.. (2006). Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clinical Microbiology and Infection. 12(3). 212–216. 56 indexed citations
10.
Personeni, Nicola, Alain Hendlisz, María Gómez Galdón, et al.. (2005). Correlation Between the Response to Cetuximab Alone or in Combination With Irinotecan and the Activated/Phosphorylated Epidermal Growth Factor Receptor in Metastatic Colorectal Cancer. Seminars in Oncology. 32(6 Suppl 9). 59–62. 29 indexed citations
11.
Akova, Murat, M Paesmans, Thierry Calandra, & Claudio Viscoli. (2004). A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of Secondary Infections in Febrile, Neutropenic Patients with Cancer. Clinical Infectious Diseases. 40(2). 239–245. 39 indexed citations
12.
Pujol, J-L., Olivier Molinier, W. Ébert, et al.. (2004). CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients. British Journal of Cancer. 90(11). 2097–2105. 164 indexed citations
13.
Martin, Bénédicte, M Paesmans, C. Mascaux, et al.. (2003). The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature. British Journal of Cancer. 89(6). 959–965. 86 indexed citations
14.
Meert, A-P, M Paesmans, Benjamín Martín, et al.. (2002). The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. British Journal of Cancer. 87(7). 694–701. 193 indexed citations
15.
Berghmans, T., M Paesmans, J.J. Lafitte, et al.. (2002). Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. Supportive Care in Cancer. 10(3). 181–188. 58 indexed citations
16.
Sculier, Jean‐Paul, Thierry Berghmans, J.J. Lafitte, et al.. (2002). A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy. Lung Cancer. 37(1). 73–77. 21 indexed citations
17.
19.
Rozenberg, Serge, et al.. (1997). Factors Influencing the Prescription of Hormone Replacement Therapy. Obstetrics and Gynecology. 90(3). 387–391. 11 indexed citations
20.
Sculier, Jean‐Paul, M Paesmans, G. Bureau, et al.. (1996). Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.. Journal of Clinical Oncology. 14(8). 2337–2344. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026